Zobrazeno 1 - 10
of 208
pro vyhledávání: '"A. Trachalaki"'
Autor:
N. Siafakas, A. Trachalaki
Publikováno v:
Pulmonology, Vol 29, Iss , Pp S86-S91 (2023)
In this review, we present the effects of lung hyperinflation on the cardiovascular system (CVS) and the beneficial outcomes of different deflation treatment modalities. We discuss the effects of long-acting bronchodilator drugs, medical and surgical
Externí odkaz:
https://doaj.org/article/cfe7cfc2a2344466a6643a5aca9f0b7c
Autor:
Siafakas, N., Trachalaki, A.
Publikováno v:
In Pulmonology December 2023 29 Supplement 4:S86-S91
Autor:
Juge, Pierre-Antoine, Solomon, Joshua J., van Moorsel, Coline H.M., Garofoli, Romain, Lee, Joyce S., Louis-Sydney, Fabienne, Rojas-Serrano, Jorge, González-Pérez, Montserrat I., Mejia, Mayra, Buendia-Roldán, Ivette, Falfán-Valencia, Ramcés, Ambrocio-Ortiz, Enrique, Manali, Effrosyni, Papiris, Spyros A., Karageorgas, Theofanis, Boumpas, Dimitrios, Antoniou, Katarina M., Sidiropoulos, Prodromos, Trachalaki, Athina, van der Vis, Joanne J., Jamnitski, Anna, Grutters, Jan C., Kannengiesser, Caroline, Borie, Raphaël, Kawano-Dourado, Leticia, Wemeau-Stervinou, Lidwine, Flipo, René-Marc, Nunes, Hilario, Uzunhan, Yurdagul, Valeyre, Dominique, Saidenberg-Kermanac'h, Nathalie, Boissier, Marie-Christophe, Richez, Christophe, Schaeverbeke, Thierry, Doyle, Tracy, Wolters, Paul J., Debray, Marie-Pierre, Boileau, Catherine, Porcher, Raphaël, Schwartz, David A., Crestani, Bruno, Dieudé, Philippe
Publikováno v:
In Seminars in Arthritis and Rheumatism October 2021 51(5):996-1004
Autor:
Tzouvelekis, Argyris, Karampitsakos, Theodoros, Gomatou, Georgia, Bouros, Evangelos, Tzilas, Vassilios, Manali, Efrossyni, Tomos, Ioannis, Trachalaki, Athina, Kolilekas, Lykourgos, Korbila, Ioanna, Tomos, Periklis, Chrysikos, Serafeim, Gaga, Mina, Daniil, Zoe, Bardaka, Fotini, Papanikolaou, Ilias C., Euthymiou, Christopher, Papakosta, Despoina, Steiropoulos, Paschalis, Ntolios, Paschalis, Tringidou, Rodoula, Papiris, Spyridon, Antoniou, Katerina, Bouros, Demosthenes
Publikováno v:
In Pulmonary Pharmacology & Therapeutics February 2020 60
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, Semeli Mastrodemou, George A. Margaritopoulos, Maria Kokosi, Dionysios Fanidis, Apostolos Galaris, Vassilis Aidinis, Elizabeth Renzoni, Nikos Tzanakis, Athol U. Wells, Katerina M. Antoniou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite management. This group of patients has been colle
Externí odkaz:
https://doaj.org/article/db8b3a2a2f2d4bf09d7b6d455f17bed9
Autor:
Eliza Tsitoura, Eirini Vasarmidi, Eleni Bibaki, Athina Trachalaki, Chara Koutoulaki, George Papastratigakis, Sevasti Papadogiorgaki, George Chalepakis, Nikos Tzanakis, Katerina M. Antoniou
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-16 (2019)
Abstract Background Impaired mitochondria homeostasis and function are established hallmarks of aging and increasing evidence suggests a link with lung fibrosis. Mitochondria homeostasis may be also affected in alveolar macrophages (AMs) in idiopathi
Externí odkaz:
https://doaj.org/article/ffe638d991294f0f9ca0f3c76805b98e
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b13ec428c75b8d5515780c548fc7dfcc
https://doi.org/10.1080/14656566.2023.2213436
https://doi.org/10.1080/14656566.2023.2213436
Autor:
Athina Trachalaki, Eliza Tsitoura, Semeli Mastrodimou, Rachele Invernizzi, Eirini Vasarmidi, Eleni Bibaki, Nikolaos Tzanakis, Philip L. Molyneaux, Toby M. Maher, Katerina Antoniou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Fibrotic Interstitial lung diseases (ILDs) are complex disorders of variable clinical behaviour. The majority of them cause significant morbidity, whilst Idiopathic Pulmonary Fibrosis (IPF) is recognised as the most relentless. NLRP3, AIM2, and NLRC4
Externí odkaz:
https://doaj.org/article/b296acba02374e95aa7cccea67198371
Autor:
Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background Fibrotic hypersensitivity pneumonitis (f-HP) can exhibit a progressive course similar to idiopathic pulmonary fibrosis (IPF). The lack of diagnostic guidelines and randomised controlled trials in this population represent a significant unm
Externí odkaz:
https://doaj.org/article/780cf796663d492282887a0f55216913